E

Euroapi SAS
PAR:EAPI

Watchlist Manager
Euroapi SAS
PAR:EAPI
Watchlist
Price: 2.764 EUR 0.88% Market Closed
Market Cap: 264.2m EUR

EV/EBIT
Enterprise Value to EBIT

-29.9
Current
45
Median
15.9
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-29.9
=
Enterprise Value
253.9m EUR
/
EBIT
-8.5m EUR
Market Cap EV/EBIT
FR
Euroapi SAS
PAR:EAPI
263.2m EUR -29.9
US
Eli Lilly and Co
NYSE:LLY
689.1B USD 36.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 17 702.3
US
Johnson & Johnson
NYSE:JNJ
369.2B USD 16.2
DK
Novo Nordisk A/S
CSE:NOVO B
2T DKK 15.1
CH
Roche Holding AG
SIX:ROG
209B CHF 11.1
CH
Novartis AG
SIX:NOVN
183.2B CHF 13.6
UK
AstraZeneca PLC
LSE:AZN
162.7B GBP 197.1
US
Merck & Co Inc
NYSE:MRK
193.7B USD 10.1
IE
Endo International PLC
LSE:0Y5F
163.5B USD 655.3
FR
Sanofi SA
PAR:SAN
117.5B EUR 6
EBIT Growth EV/EBIT to Growth
FR
E
Euroapi SAS
PAR:EAPI
Average EV/EBIT: 1 866.3
Negative Multiple: -29.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.5
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
16.2
13%
1.2
DK
Novo Nordisk A/S
CSE:NOVO B
15.1
14%
1.1
CH
Roche Holding AG
SIX:ROG
11.1
6%
1.8
CH
Novartis AG
SIX:NOVN
13.6
10%
1.4
UK
AstraZeneca PLC
LSE:AZN
197.1
21%
9.4
US
Merck & Co Inc
NYSE:MRK
10.1
12%
0.8
IE
E
Endo International PLC
LSE:0Y5F
655.3
N/A N/A
FR
Sanofi SA
PAR:SAN
6
14%
0.4

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
-6.5
2-Years Forward
EV/EBIT
-14.9
3-Years Forward
EV/EBIT
10.5